Don't forget Inavir is once a week as apposed to daily. Others factors should be taken into account. Seems like an over reaction but given market sentiment towards BTA it comes as no surprise. Yet another reason to move the investor base to the NASDAQ.
Yes a difference between actual and target but still a very nice result considering the once a week dose.
